SAME Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Sarana Meditama Metropolitan Tbk PT

Watchlist Manager

Watchlist

Price: 296 IDR Market Closed

Market Cap: Rp5.1T

	Sarana Meditama Metropolitan Tbk PT IDX:SAME	ID
T	Takeda Pharmaceutical Co Ltd XMUN:TKD	JP
R	Realtech AG XMUN:RTC	DE
V	Vectron Systems AG F:V3S	DE
T	TTY Biopharm Co Ltd TPEX:4105	TW
	Franklin BSP Realty Trust Inc F:6VH	US
M	M31 Technology Corp TPEX:6643	TW
M	Muenchener Rueckversicherungs-Gesellschaft in Muenchen AG XHAN:MUV2	DE

Profitability Summary

Sarana Meditama Metropolitan Tbk PT's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

29%

Sustainable 3Y Average Gross Margin

32%

Declining Gross Margin

36% > 29%

Low Operating Margin

Low 3Y Average Operating Margin

Operating Margin is Increasing

4% > 6%

Low Net Margin

Low 3Y Average Net Margin

Declining Net Margin

2% > 1%

Healthy Free Cash Flow Margin

Negative 3Y Average Free Cash Flow Margin

-9%

Free Cash Flow Margin is Increasing